Study of care for dangerously high blood pressure
Part of Heart & circulation clinical trials.
This trial looks at a health-care plan for people with malignant hypertension (very high blood pressure causing emergency eye and organ damage). It may help doctors better organize treatment and follow-up after this high-risk diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have malignant hypertension, meaning blood pressure above 180/110 with severe eye damage
- Your severe high blood pressure (above 180/110) is causing sudden injury to 3 body organs
- You can understand the study and agree to join
- You are not on dialysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have had a severe, sudden rise in blood pressure (malignant hypertension) that caused damage to organs like the eyes, kidneys, or heart. Researchers want to understand what leads to this dangerous condition and why it affects different organs.
This trial aims to see how well commonly used blood pressure medicines work in people with high blood pressure. It focuses on patients whose blood pressure is at least 140/80 and who have been diagnosed with essential hypertension.
This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.
This trial is studying how changes in blood pressure affect the tiny blood vessels in the back of the eye (retina). It may help people with high blood pressure understand how treatment impacts their eye health.
This trial studies a new way to help people with high blood pressure get better control of their numbers. It uses a team approach to support you in managing your blood pressure and lowering your risk for heart problems.
This trial tests a personalized approach to treating high blood pressure based on the specific causes of your condition. It aims to see if individual treatment plans are more effective than standard care.
Hear when a new Malignant Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.